Effect of Persea macrantha against acute inflammation and adjuvant-induced arthritis in rats

Pharmaceutical Biology

Volumn 47, Issue 4, 2009, Pages 304-308

  Kulkarni, Y A ^a   Gokhale, S B ^a   Veeranjaneyulu, A ^a   Surana, S J ^b   Tatiya, A U ^b  

^a Shri Vile Parle Kelavani Mandal's Narsee Monjee Institute of Management Studies   (India)

^b R C PATEL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

Author keywords

Anti arthritic activity; Anti inflammatory activity; Complete Freund's adjuvant; Machilus macrantha; Persea macrantha; Radiological

Indexed keywords

CARRAGEENAN; DICLOFENAC; PERSEA MACRANTHA EXTRACT; PETROLEUM ETHER; PLANT EXTRACT; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIARTHRITIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; AQUEOUS SOLUTION; ARTICLE; AVOCADO; BARK; CONTROLLED STUDY; DRUG ACTIVITY; LD 50; MALE; NONHUMAN; PAW EDEMA; PERSEA MACRANTHA; PLANT STEM; RAT;

ANIMALIA; LAURACEAE; MACHILUS; PERSEA; RATTUS;

EID: 77149150964     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.1080/13880200902748437     Document Type: Article

References (16)

1. Badger AM, Lee JC (1997): Advances in antiarthritic therapeutics. Drug Discovery Today 2: 427-435.
2. Conway JG, Wakefield JA, Brown RH, Marron BE, Sekut L, Stimpson SA, McElroy A, Menius JA, Jeffreys JJ, Clark RL, Gerard M McGeehan, Connollyll KM (1995): Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor. J Exp Med 182: 449-457.
3. Goldenberg MM, Use AC (1977): Anti-inflammatory activity of EU-2972. Arch Int Pharmacodynamics 228: 153-161.
4. Khanna D, Sethi G, Ahn KS, Pandey MK, Kunnumakkara A B, Sung B, Aggarwal A, Aggarwal BB (2007): Natural products as a gold mine for arthritis treatment. Curr Opin Pharmacol 7: 344-351.
5. Kirtikar KR, Basu BD (1999): Indian Medicinal Plants, Vol. III, Dehradun, International Book Distributors, p. 2155.
6. Nadkarni KM (2000). Indian Materia Medica. Vol. I, Mumbai, Popular Prakashan, p. 759.
7. Nantel F, Denis D, Gordon R, Northey A, Cirino M., Metters KM, Chan CC (1999): Distribution and regulation of cyclooxygenase-2 in carrageenan-induced inflammation. Braz J Pharmacol 128:853-859.
8. Newbould BB (1963): Chemotherapy of arthritis induced in rats by mycobacterial adjuvant. Brit J Pharmacol 21: 127-136.
9. Noguchi M, Kimoto A, Kobayashi S, Yoshino T, Miyata K, Sasamata M (2005): Effect of celecoxib, a cyclooxygenase-2-inhibitor, on pathophysiology of adjuvant induced arthritis in rat. Eur J Pharmacol 513: 229-235.
10. OECD (Organization of Economic Co-operation Development) (2001): The OECD Guideline for Testing of Chemical: 420 Acute Oral Toxicity. OECD, Paris, pp. 1-14.
11. Pearson CM, Wood FD (1959): Studies on polyarthritis and other lesions induced in rats by the injection of mycobacterial adjuvant: I. General clinical and pathological characteristics and some modifying factors. Arth Rheum 2: 440-459.
12. Singh S, Majumdar DK (1996): Effect of fixed oil of Ocimum sanctum against experimentally induced arthritis and joint edema in laboratory animals. Int J Pharmacog 34: 218-222.
13. Spector WG (1960): The inflammatory response. J Path Bact 84: 391-403.
14. Ueno A, Naraba H, Ikeda Y, Ushikubi F, Murata T, Naramiya S, Ohishi S (2000): Intrinsic prostacyclin contributes to exudation induced by bradikinin or carrageenan: A study on the paw edema induced in ip-receptor-deficient mice. Life Science 66: 155-160.
15. Vogel GH (2002): Drug Discovery and Evaluation: Pharmacological Assays, Berlin, Heidelberg, New York, Springer, pp. 696, 802-803.
16. Winter CA, Risley EA, Nuss GW (1962): Carrageenan-induced edema in hind paw of the rats as an assay for anti-inflammatory drugs. ProcSoc Exp Biol Med 111: 544-554.